当前位置：
X-MOL 学术
›
N. Engl. J. Med.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
The New England Journal of Medicine ( IF 96.2 ) Pub Date : 2022-12-11 , DOI: 10.1056/nejmoa2206913 Michael J. Dickinson 1 , Carmelo Carlo-Stella 1 , Franck Morschhauser 1 , Emmanuel Bachy 1 , Paolo Corradini 1 , Gloria Iacoboni 1 , Cyrus Khan 1 , Tomasz Wróbel 1 , Fritz Offner 1 , Marek Trněný 1 , Shang-Ju Wu 1 , Guillaume Cartron 1 , Mark Hertzberg 1 , Anna Sureda 1 , David Perez-Callejo 1 , Linda Lundberg 1 , James Relf 1 , Mark Dixon 1 , Emma Clark 1 , Kathryn Humphrey 1 , Martin Hutchings 1
The New England Journal of Medicine ( IF 96.2 ) Pub Date : 2022-12-11 , DOI: 10.1056/nejmoa2206913 Michael J. Dickinson 1 , Carmelo Carlo-Stella 1 , Franck Morschhauser 1 , Emmanuel Bachy 1 , Paolo Corradini 1 , Gloria Iacoboni 1 , Cyrus Khan 1 , Tomasz Wróbel 1 , Fritz Offner 1 , Marek Trněný 1 , Shang-Ju Wu 1 , Guillaume Cartron 1 , Mark Hertzberg 1 , Anna Sureda 1 , David Perez-Callejo 1 , Linda Lundberg 1 , James Relf 1 , Mark Dixon 1 , Emma Clark 1 , Kathryn Humphrey 1 , Martin Hutchings 1
Affiliation
New England Journal of Medicine, Ahead of Print.
中文翻译：
用于复发或难治性弥漫性大 B 细胞淋巴瘤的 Glofitamab
新英格兰医学杂志，印刷前。
更新日期：2022-12-12
中文翻译：
用于复发或难治性弥漫性大 B 细胞淋巴瘤的 Glofitamab
新英格兰医学杂志，印刷前。
京公网安备 11010802027423号